Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 8, 2013, Pages 909-914

  Dobson, Ruth ^a   Ramagopalan, Sreeram ^a,b   Davis, Angharad ^a   Giovannoni, Gavin ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOCLONAL BAND;

ARTICLE; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; HUMAN; LATITUDE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 84879910017     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304695     Document Type: Article

References (31)

1. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
2. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005;62:865 -70.
3. Ohman S, Ernerudh J, Forsberg P, et al. Comparison of seven formulae and isoelectrofocusing for determination of intrathecally produced IgG in neurological diseases. Ann Clin Biochem 1992;29(Pt 4):405-10.
4. Kostulas VK, Link H, Lefvert AK. Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients. Arch Neurol 1987;44:1041 -4.
5. McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain 1990;113(Pt 5):1269-89. (Pubitemid 20385912)
6. Davies G, Keir G, Thompson EJ, et al. The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study. Neurology 2003;60:1163 -6.
7. Lechner-Scott J, Spencer B, de Malmanche T, et al. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler 2012;18:974-82.
8. Tintore M, Rovira A, Rio J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008;70(13 Pt 2):1079-83. (Pubitemid 351464763)
9. Ried K. Interpreting and understanding meta-analysis graphs-a practical guide. Aust Fam Physician 2006;35:635 -8.
10. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
11. Egger M, Davey Smith G, Schneider M, et al . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
12. Chang KH, Lyu RK, Chen CM, et al. Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. Mult Scler 2006;12:501-6.
13. Nakashima I, Fujihara K, Miyazawa H, et al. Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis. Acta Neurol Scand 2006;113:125-31.
14. Li B, Dong H, Zhang J, et al. Cerebrospinal fluid IgG pro files and oligoclonal bands in Chinese patients with multiple sclerosis. Acta Neurol Scand 2007;115:319-24. (Pubitemid 46699427)
15. Mandrioli J, Sola P, Bedin R, et al. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease. J Neurol 2008;255:1023-31.
16. Rojas JI, Tizio S, Patrucco L, et al. Oligoclonal bands in multiple sclerosis patients: worse prognosis? Neurol Res 2012;34:889- 92.
17. Imrell K, Greiner E, Hillert J, et al. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis. J Neuroimmunol 2009;210:128-30.
18. Koch M, Heersema D, Mostert J, et al. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis. Eur J Neurol 2007;14:797-800. (Pubitemid 47012193)
19. Balnyte R, Rastenyte D, Uloziene I, et al. The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability. Medicina (Kaunas) 2011;47:368 -73.
20. Siritho S, Freedman MS. The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci 2009;279:21-5.
21. Idiman E, Ozakbas S, Dogan Y, et al. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds. J Neuroimmunol 2009;212:121-4.
22. Cordonnier C, de Seze J, Breteau G, et al. Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 2003;250:1447- 52.
23. Sola P, Mandrioli J, Simone AM, et al. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM. Mult Scler 2011;17:303-11.
24. Kikuchi S, Fukazawa T, Niino M, et al. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 2003;60:647-51. (Pubitemid 36246084)
25. Saadatnia M, Najafi MR, Najafi F, et al. CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients. Neuroimmunomodulation 2012;19:195 -9.
26. Imrell K, Landtblom A, Hillert J, et al. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 2006;67:1062-4. (Pubitemid 44454606)
27. Horwitz H, Degn M, Modvig S, et al. CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis. J Neurol 2012; 259:2616-20.
28. Soderstrom M, Ya-Ping J, Hillert J, et al. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 1998;50:708- 14.
29. Sastre-Garriga J, Tintore M, Rovira A, et al. Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler 2003;9:39-43. (Pubitemid 36253695)
30. Solomon AJ, Klein EP, Bourdette D. "Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS. Neurology 2012;78:1986-91.
31. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9(5):520-32. Clinical Research Fellowship